TSS
MDVX

Two Sigma Securities’s Medovex Corp. Common Stock MDVX Stock Holding History

Two Sigma Securities’s Portfolio MDVX Stock Details MDVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-38,781
Closed -$51K – 857
2016
Q2 		$51K Buy
+38,781
New +$52.7K 0.03% 340

Other funds holding MDVX

MIC
Meridian Investment Counsel Lafayette, California $466M AUM 42.29% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Securities's MDVX Position: Q3 2016 in Review

Two Sigma Securities sold out of Medovex Corp. Common Stock (MDVX) in Q3 2016, closing a stake of 38,781 shares — an estimated $51K sold.

Two Sigma Securities first reported a position in MDVX in Q2 2016 and held it in 1 quarter. The position peaked at $51K in Q2 2016. 10 funds tracked by Wall St. Rank hold MDVX as of Q3 2016.

  • Two Sigma Securities reported no remaining Medovex Corp. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Two Sigma Securities sold 38,781 Medovex Corp. Common Stock shares in Q3 2016, an estimated $51K.
  • Two Sigma Securities first reported a position in Medovex Corp. Common Stock in Q2 2016 and held it in 1 quarter.
  • Two Sigma Securities's Medovex Corp. Common Stock position peaked at $51K in Q2 2016.
  • 10 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q3 2016.

Based on Two Sigma Securities's 13F filing for Q3 2016, filed 14 Nov 2016.